STAMFORD, Conn., Nov. 01, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres” or the “Company”) on behalf of the Company’s investors. The investigation seeks to determine whether Seres’s board of directors (the “Board”) has violated its fiduciary duty by instituting measures intended to…Read More
INVESTOR ALERT Abbott Cooper PLLC Announces Investigation into Seres Therapeutics Inc Urges Seres Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
